Serum (1→3)-β-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii

Journal of Clinical Microbiology

Volumn 49, Issue 5, 2011, Pages 2000-2002

  Damiani, Céline ^a,b   Le Gal, Solène ^c,d   Lejeune, Delphine ^a   Brahimi, Naima ^a   Virmaux, Michèle ^c   Nevez, Gilles ^c,d   Totet, Anne ^a,b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^c UNIVERSITÉ DE BREST   (France)

^d BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; BETA GLUCAN; BETA-1,3-D-GLUCAN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FUNGAL COLONIZATION; FUNGAL DETECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INFANT; LUNG CARCINOMA; LUNG LAVAGE; LUNG SARCOIDOSIS; MALE; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS JIROVECI INFECTION; PNEUMOCYSTIS PNEUMONIA; PNEUMOCYSTOSIS; PRIORITY JOURNAL; BLOOD; CHEMISTRY; HETEROZYGOTE; ISOLATION AND PURIFICATION; LUNG MYCOSIS; SERUM;

PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII;

BETA-GLUCANS; BIOLOGICAL MARKERS; CARRIER STATE; FEMALE; HUMANS; INFANT; LUNG DISEASES, FUNGAL; MALE; PNEUMOCYSTIS INFECTIONS; PNEUMOCYSTIS JIROVECII; SERUM;

EID: 79955545072     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00249-11     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. 1992. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb. Mortal. Wkly. Rep. 41:1-19.
2. Cuetara, M. S., et al. 2008. Use of a serum (1→3)-beta-D-glucan assay for diagnosis and follow-up of Pneumocystis jirovecii pneumonia. Clin. Infect. Dis. 47:1364-1366.
3. de Boer, M. G., et al. 2011. β-D-Glucan and s-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative patients: a prospective study. J. Infect. 63:93-100.
4. Dei-Cas, E., E. M. Aliouat, and J. C. Caillez. 2005. Pneumocystis cellular structure, p. 61-94. In P. D. Walzer and M. Cushion (ed.), Pneumocystis pneumonia, 3rd ed. Marcel Dekker, New York, NY.
5. Del Bono, V., et al. 2009. Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. Clin. Vaccine Immunol. 16:1524-1526.
6. Desmet, S., et al. 2009. Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J. Clin. Microbiol. 47:3871-3874.
7. Finkelman, M. A. 2010. Pneumocystis jirovecii infection: Cell wall (1→3)-β- D-glucan biology and diagnostic utility. Crit. Rev. Microbiol. 36:271-281.
8. Held, J., M. Koch, U. Reischl, T. Danner, and A. Serr. 2010. Serum (1→3)- beta-D-glucan measurement as early indicator for Pneumocystis jirovecii pneumonia and evaluation of its prognostic value. Clin. Microbiol. Infect. doi:10.1111/j.1469-0691.2010.03318.x.
9. Marty, F. M., S. Koo, J. Bryar, and L. R. Baden. 2007. (1→3) beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia. Ann. Intern. Med. 147:70-72.
10. Meliani, L., et al. 2003. Real time quantitative PCR assay for Pneumocystis jirovecii detection. J. Eukaryot. Microbiol. 50(Suppl.):651.
11. Nakamura, H., et al. 2009. Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia. Intern. Med. 48:195-202.
12. Persat, F., et al. 2008. Contribution of the (1→3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 46:1009-1013.
13. Peterson, J. C., and M. T. Cushion. 2005. Pneumocystis: not just pneumonia. Curr. Opin. Microbiol. 8:393-398.
14. Pisculli, M. L., and P. E. Sax. 2008. Use of a serum beta-glucan assay for diagnosis of HIV-related Pneumocystis jiroveci pneumonia in patients with negative microscopic examination results. Clin. Infect. Dis. 46:1928-1930.
15. Shimizu, A., H. Oka, T. Matsuda, and S. Ozaki. 2005. (1→3)-Beta-D glucan is a diagnostic and negative prognostic marker for Pneumocystis carinii pneumonia in patients with connective tissue disease. Clin. Exp. Rheumatol. 23:678-680.
16. Shimizu, Y., et al. 2009. Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study. BMC Infect. Dis. 9:47.
17. Tasaka, S., et al. 2007. Serum indicators for the diagnosis of Pneumocystis pneumonia. Chest 131:1173-1180. (Pubitemid 46608722)
18. Totet, A., et al. 2003. Immunocompetent infants as a human reservoir for Pneumocystis jirovecii: rapid screening by non-invasive sampling and realtime PCR at the mitochondrial large subunit rRNA gene. J. Eukaryot. Microbiol. 50(Suppl.):668-669.
19. Vargas, S. L., et al. 2001. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin. Infect. Dis. 32:855-861.
20. Watanabe, T., et al. 2009. Serum (1→3) beta-D-glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin. Infect. Dis. 49:1128-1131.